ABT vs VNDA · P/E 25, rev $44.33B vs rev $102.2M
Abbott Laboratories (ABT) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the ABT and VNDA stock pages for the full models.
Not investment advice.